Company Avricore Health Inc Toronto S.E.
Equities
APH
CA92143R2046
Pharmaceuticals
Business Summary
Sales per Business
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Health Data and Point-of-care Technologies
100.0
%
| 0 | 100.0 % | 2 | 100.0 % | +1,339.95% |
Sales per region
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 0 | 100.0 % | 2 | 100.0 % | +1,339.95% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hector Bremner
CEO | Chief Executive Officer | - | 18-12-31 |
Kiki Smith
DFI | Director of Finance/CFO | - | 19-08-05 |
Rodger Seccombe
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-07 |
Mark Kunzli
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Hall
CHM | Chairman | 71 | 16-01-19 |
Robert Sindelar
BRD | Director/Board Member | 71 | 18-03-26 |
Christine Hrudka
BRD | Director/Board Member | - | 23-06-20 |
Rodger Seccombe
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-07 |
Alan Arnstein
BRD | Director/Board Member | 56 | 17-04-19 |
Hector Bremner
CEO | Chief Executive Officer | - | 18-12-31 |
Thomas Teahen
BRD | Director/Board Member | - | 23-06-20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 99,869,664 | 90,194,935 ( 90.31 %) | 0 | 90.31 % |
Company contact information
Avricore Health, Inc.
789 West Pender Street Suite 1120
V6C 1H2, Vancouver
+
http://www.avricorehealth.comSector
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |